Rob Webster
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Virology 5
- HIV Research and Treatment 5
-
- HIV/AIDS drug development and treatment 8
- Co-authors
- Manos Perros (5 shared papers)Anthony Wood (4 shared papers)Mike Westby (4 shared papers)David Anthony Price (2 shared papers)Carolyn M. Napier (1 shared paper)Patrick K. Dorr (1 shared paper)Paul Griffin (1 shared paper)Julie Mori (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (7 papers)Xenobiotica (3 papers)ChemMedChem (3 papers)Drug Metabolism and Disposition (2 papers)MedChemComm (2 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Rob Webster
31 papers receiving 2.4k citations
Rob Webster's Hit Papers
Peers
Comparison fields: 5 of 124
- Virology 625
- Infectious Diseases 465
- Pharmacology 192
- Immunology 278
- Pharmaceutical Science 81
Countries citing papers authored by Rob Webster
This map shows the geographic impact of Rob Webster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Webster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Webster more than expected).
Fields of papers citing papers by Rob Webster
This network shows the impact of papers produced by Rob Webster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Webster. The network helps show where Rob Webster may publish in the future.
Co-authors
The 25 scholars most cited alongside Rob Webster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity Hit paper breakdown → | 2005 | 965 |
| 2 | 2006 | 305 | |
| 3 | 2009 | 242 | |
| 4 | 2009 | 161 | |
| 5 | 2011 | 133 | |
| 6 | Towards a drug concentration effect relationship for QT prolongation and torsades de pointes. | 2002 | 103 |
| 7 | 2009 | 93 | |
| 8 | 2008 | 58 | |
| 9 | 2012 | 43 | |
| 10 | 2001 | 35 | |
| 11 | 2007 | 35 | |
| 12 | 2016 | 35 | |
| 13 | 2008 | 32 | |
| 14 | 2009 | 31 | |
| 15 | 2014 | 30 | |
| 16 | 2012 | 30 | |
| 17 | 2018 | 30 | |
| 18 | 2007 | 27 | |
| 19 | 2009 | 26 | |
| 20 | 2011 | 22 |
About Rob Webster
Rob Webster is a scholar working on Virology, Infectious Diseases, Pharmacology, Hepatology and Radiology, Nuclear Medicine and Imaging, having authored 31 papers that have together received 2.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), HIV Research and Treatment (5 papers), Pharmacogenetics and Drug Metabolism (5 papers), Protein purification and stability (3 papers), Pharmacological Effects and Assays (3 papers), Biochemical and Molecular Research (3 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Virology (625 citations), Infectious Diseases (465 citations), Pharmacology (192 citations), Immunology (278 citations) and Pharmaceutical Science (81 citations). Rob Webster has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Manos Perros, Anthony Wood, Mike Westby, David Anthony Price, Carolyn M. Napier, Patrick K. Dorr, Paul Griffin, Julie Mori, Malcolm J. Macartney and Blanda Stammen. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Xenobiotica, ChemMedChem, Drug Metabolism and Disposition and MedChemComm.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.